Showing results (531-540 of 1,357) with videos related to
Sort By:
Pageof 136
Molecular Pharmacology|November 1, 1986
Phenylarsine oxide inhibits agonist-induced changes in photolabeling but not agonist-induced desensitization of the beta-adrenergic receptorR D Feldman, W McArdle, C LaiClinical and Experimental Rheumatology|January 17, 2002
A double-blind, randomized, controlled study of amitriptyline, nortriptyline and placebo in patients with fibromyalgia. An analysis of outcome measuresR E Heymann, M Helfenstein, D FeldmanEndocrinology|March 1, 1981
1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in cultureK Colston, M J Colston, D FeldmanThe Canadian Journal of Cardiology|April 2, 2014
β-adrenoceptors as molecular targets in the treatment of hypertensionStephen S G Ferguson, Ross D FeldmanAnnals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|April 20, 2021
Munchausen by internet and false perinatal crisesKathryn V J Newns, Marc D FeldmanThe Journal of Endocrinology|November 1, 1987
Isolation, amino acid sequence and action of guinea-pig ACTH on aldosterone production by glomerulosa cellsA I Smith, C A Wallace, R L Moritz, et al.Endocrinology|July 1, 1989
Immunolocalization of renal mineralocorticoid receptors with an antiserum against a peptide deduced from the complementary deoxyribonucleic acid sequenceZ S Krozowski, S E Rundle, C Wallace, et al.Endocrinology|January 1, 1975
Cytoplasmic glucocorticoid binding proteins in bone cellsD Feldman, R Dziak, R Koehler, et al.Advances in Experimental Medicine and Biology|January 1, 1995
Vitamin D and prostate cancerD Feldman, R J Skowronski, D M PeehlEndocrinology|January 1, 1995
Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3R J Skowronski, D M Peehl, D FeldmanPageof 136